As of Jun 22
| -0.0612 / -6.18%|
The 4 analysts offering 12-month price forecasts for Genocea Biosciences Inc have a median target of 4.00, with a high estimate of 5.00 and a low estimate of 3.00. The median estimate represents a +330.76% increase from the last price of 0.93.
The current consensus among 4 polled investment analysts is to Buy stock in Genocea Biosciences Inc. This rating has held steady since June, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.